Few & Far Between: Conversations from the Front Lines of Drug Development
Chris O'Brien
35 episodes
1 week ago
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
All content for Few & Far Between: Conversations from the Front Lines of Drug Development is the property of Chris O'Brien and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
Few & Far Between: Conversations from the Front Lines of Drug Development
43 minutes 41 seconds
2 months ago
Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech
What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast.
Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima Biotech, to the podcast. Tune in to part one of this special two-part episode as we double-click on #AIagents, building neural networks, and syncing visual biology with real-world biology.
Okay, let's start the podcast!
Few & Far Between: Conversations from the Front Lines of Drug Development
Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for Conversations from the Front Lines of Drug Development - from clinical research and policymakers to biotech innovators and industry leaders.
